Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-26T13:01:03.875Z Has data issue: false hasContentIssue false
  • English
  • Français

Depot antipsychotic prophylaxis in bipolar affective disorder

Published online by Cambridge University Press:  13 June 2014

L Mannion ,
PA Carney ,
D Sloan  and
R O'Toole
R O'Toole
Affiliation:
Department of Psychiatry, University College Hospital, Galway, Ireland
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective: Depot antipsychotic medication is often prescribed as maintenance treatment for patients with bipolar affective disorder. In this study we examined the case notes of 14 patients with bipolar disorder who had been prescribed depot antipsychotics. Our aim was to establish the effectiveness of depot medication in this group.

Method: We calculated the total number of hospital admissions, length of hospital stay, and total number of affective episodes for each patient from the onset of their illness to the time of the study. The frequency of affective episodes and hospital admission were compared during periods on or off depot medication.

Results: Treatment with depot antipsychotics was associated with a significant decrease in the number of hospital admissions, overall affective episodes and manic episodes in particular.

Conclusions: Prophylactic treatment with depot antipsychotics may be useful for certain patients with bipolar disorder, in particular those patients who experience frequent manic episodes. Further proof of the efficacy of depot antipsychotics in the prophylaxis of bipolar affective disorder requires the completion of a double-blind prospective trial.

Keywords

Bipolar disorderDepotProphylacticsAntipsychotics
Type
Brief Reports
Information
Irish Journal of Psychological Medicine , Volume 16 , Issue 2 , June 1999 , pp. 64 - 66
Copyright
Copyright © Cambridge University Press 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Prien, R, Potter, W. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 1990; 26: 409–27.Google ScholarPubMed
2.Maarbjerg, K, Aagard, J, Vestergaard, P. Adherence to lithium prophylaxis: Clinical predictors and patient's reasons for non-adherence. Pharmacopsychiat 1988; 21: 121–5.CrossRefGoogle Scholar
3.Peselow, E, Fieve, R, DiFiglia, C, Sanfilipo, M. Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiat 1994; 164: 208–15.CrossRefGoogle ScholarPubMed
4.Verdoux, H, Gonzales, B, Takei, N, Bourgeois, M. A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996; 38: 81–7.CrossRefGoogle ScholarPubMed
5.American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiat 1994; 12: 1–36.Google Scholar
6.Naylor, J, Scott, C. Depot injections for affective disorders. Br J Psychiat 1980; 5: 108.Google Scholar
7.Lowe, M, Batchelor, D. Depot neuroleptics and manic depressive psychosis. Int J Clin Psychopharmacol 1986; suppl: 53–62.Google Scholar
8.White, E, Cheung, P, Silverstone, T. Depot antipsychotics in bipolar affective disorder. Internat Clin Psychopharmacol 1993; 8: 119–22.CrossRefGoogle ScholarPubMed
9.Littlejohn, R, Leslie, F, Cookson, J. Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiat 1994; 165: 827–9.CrossRefGoogle ScholarPubMed
10.Esparon, J, Kolloori, J, Naylor, G, Mc, Harg A, Amith, AH, Hopwood, S. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic depressive patients. Br J Psychiat 1986; 148: 723–5.CrossRefGoogle ScholarPubMed
11.Ahlfors, U, Baastrup, P, Dencker, Set al.Flupenthixol decanoate in recurrent manic depressive illness: A comparison with lithium. Acta Psychiat Scand 1981; 226–37.CrossRefGoogle ScholarPubMed